FUZIONAIRE THERANOSTICS
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2002 Timberloch Pl Ste 200, The Woodland...Website
www.fuzionairetx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About FUZIONAIRE THERANOSTICS
Fuzionaire Theranostics is a radiopharmaceutical company focused on developing a powerful new platform for diagnosing, studying, and treating diseases, particularly cancer. Leveraging a breakthrough chemical platform from Nobel laureate Robert Grubbs' lab, the company aims to make theranostic treatments more accessible, combining PET diagnostics with radioligand therapy for personalized cancer care. Their HetSiFA platform enables the production of chemically identical diagnostic and therapeutic companions tailored for each cancer patient, utilizing advanced radionuclides such as fluorine-18 and actinium-225. The company's growing pipeline includes innovative solutions targeting specific cancers, such as metastatic prostate cancer.Explore more
Popular SearchesFUZIONAIRE THERANOSTICS IncFuzionaire TheranosticsSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is FUZIONAIRE THERANOSTICS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if FUZIONAIRE THERANOSTICS is spiking on competitors!
Funding: Get notified immidiatlly once FUZIONAIRE THERANOSTICS has new funding data
Product Launch: Get notified when FUZIONAIRE THERANOSTICS launches new products
Congratulate Masked Content for being promoted to Masked Content at FUZIONAIRE THERANOSTICS
Earning: See what the market has to say on FUZIONAIRE THERANOSTICS recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if FUZIONAIRE THERANOSTICS has recently received funding, and reach out quickly before it becomes old news!
FUZIONAIRE THERANOSTICS, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if FUZIONAIRE THERANOSTICS had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to FUZIONAIRE THERANOSTICS
Compare insights from companies similar to FUZIONAIRE THERANOSTICS, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
FUZIONAIRE THERANOSTICS
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
FUZIONAIRE THERANOSTICS is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
FUZIONAIRE THERANOSTICS is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about FUZIONAIRE THERANOSTICS.
FUZIONAIRE THERANOSTICS Tech Stack
A closer look at the technologies used by FUZIONAIRE THERANOSTICS
See more technologies
FUZIONAIRE THERANOSTICS News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding FUZIONAIRE THERANOSTICS
Sign Up For FreeTo access detailed company insights
Fuzionaire Theranostics is a radiopharmaceutical company focused on developing a powerful new platform for diagnosing, studying, and treating diseases, particularly cancer. Leveraging a breakthrough chemical platform from Nobel laureate Robert Grubbs' lab, the company aims to make theranostic treatments more accessible, combining PET diagnostics wi... Read More
